Access
Your GLP-1 Prior Authorisation Was Denied. Here Is What Actually Works.
Medically reviewed by Dr. J. Adam, MD · Updated July 23, 2026 · Sources cited below
Most prior-authorisation denials are documentation failures rather than judgements on merit. The critical first step is establishing whether you received a denial — criteria judged unmet, which is appealable on evidence — or hit a plan exclusion, where the category is not covered at all and appealing the clinical criteria cannot work.
Key takeaways
- A denial and an exclusion are different problems requiring different responses.
- Most denials fail on incomplete documentation rather than on clinical merit.
- Commercial plans generally offer an internal appeal followed by independent external review.
- Appeal deadlines run from the denial date and forfeiting them closes the route.
- An additional approved indication can open a coverage category a weight-loss request cannot.
| Most common cause | Incomplete documentation |
|---|---|
| Denial | Criteria judged unmet — appealable on evidence |
| Exclusion | Category not covered — clinical appeal cannot succeed |
| Typical ladder | Internal appeal, then external review |
| Deadline | Runs from the denial date; varies by plan |
| Alternative route | Different approved indication, or manufacturer cash channel |
First: which problem do you actually have?
Read the denial letter for the reason code rather than the summary. A denial says the plan covers the drug in principle but has judged this request as not meeting its criteria — usually documentation of BMI, comorbidities or prior weight-management attempts. Supplying what was missing frequently resolves it.
An exclusion says the plan does not cover this category of drug at all, typically as an employer benefit-design decision. No amount of clinical documentation changes that, because the criteria were never the obstacle.
Getting this wrong wastes the appeal window. People routinely submit detailed medical-necessity letters against an exclusion and receive the same answer, having burned weeks.
View chart data as a table
| Covered with savings card | 25 |
|---|---|
| Manufacturer cash channel | 449 |
| Retail without coverage | 1086 |
What documentation actually moves a denial
Height, weight and calculated BMI recorded in the chart rather than reported by the patient. Documented weight-related comorbidities — hypertension, dyslipidaemia, obstructive sleep apnoea, prediabetes — with their diagnosis codes. A record of prior weight-management attempts including dates and outcomes.
Then a prescriber statement of medical necessity that addresses the plan's specific criteria rather than making a general case. Template letters are recognisable and land poorly; a letter that quotes the criterion and answers it with a document does not.
Assemble this before submitting rather than after a denial. The single highest-return action in this whole process is a complete first submission, because it avoids the appeal entirely.
What to do when it is an exclusion
Three routes remain, in rough order of likelihood. A formulary exception on medical necessity, which asks the plan to cover something outside its formulary because alternatives are unsuitable — this succeeds more often when there is a documented failure or intolerance of covered alternatives.
A different approved indication. Tirzepatide's approval for moderate-to-severe obstructive sleep apnoea in adults with obesity sits in a different benefit category from weight management, and plans that exclude the latter frequently cover the former. This requires a genuine diagnosis with a sleep study, not a reframing.
An employer benefit change, which is slow but is the actual decision-maker for most exclusions. HR and benefits teams do respond to employee demand at renewal, and this is worth raising even though it will not help this month.
| Situation | What it means | Route that can actually work |
|---|---|---|
| Prior authorisation required | Covered, documentation wanted first | Complete submission: BMI, comorbidities, prior attempts |
| Authorisation denied | Criteria judged unmet | Internal appeal, then external review |
| Weight management excluded | Category not in the benefit | Formulary exception, different indication, or employer change |
| Step therapy imposed | Must try another agent first | Document intolerance or failure of the required agent |
| Quantity limit applied | Dose or supply restricted | Prescriber justification for the dose reached |
How the appeal ladder works
Commercial plans generally provide an internal appeal, decided by the insurer, followed by an independent external review decided outside it. The external stage matters because it removes the conflict inherent in an insurer reviewing its own denial, and it succeeds in cases the internal stage rejected.
Both stages have filing deadlines that run from the denial date, and they are not generous. Calendar them the day the denial arrives rather than when you get round to responding.
Ask for the plan's clinical criteria in writing at the start. An appeal built against the actual criteria succeeds far more often than one built against assumptions about what the plan wants.
What to do while it is in progress
Appeals take weeks. If starting treatment matters clinically, the manufacturer cash channels are available in the meantime and do not prejudice an appeal — paying cash for a month does not constitute accepting the denial.
Keep every document. If the appeal succeeds, some plans will reimburse costs incurred during the review period, and having dated receipts and the approval letter together makes that claim straightforward rather than a second dispute.
Finally, revisit annually. Formularies change at plan renewal, and a category excluded this year is sometimes covered next year, particularly as additional indications are approved.
Frequently asked questions
Why was my GLP-1 prior authorisation denied?
Most commonly incomplete documentation of BMI, comorbidities or prior attempts rather than a judgement on clinical merit.
What is the difference between a denial and an exclusion?
A denial says criteria were unmet and is appealable on evidence. An exclusion means the plan does not cover the category at all.
Is an appeal worth the effort?
Given the spread between a covered copay and cash pricing, it is usually the highest-value hour available.
What is external review?
An appeal stage decided independently of the insurer, generally available after the internal appeal is exhausted.
Can I pay cash while appealing?
Yes, and it does not prejudice the appeal. Keep dated receipts in case the plan reimburses.
Sources
Every clinical claim above links to a primary source: an FDA record, a peer-reviewed publication with DOI or PMID, or a ClinicalTrials.gov registration. Where a figure could not be verified against a primary source, it is labelled rather than asserted.
rel="nofollow noopener". Rankings follow our
published methodology. See conflicts
of interest. This article is information, not medical advice.